---
pmid: '11461089'
title: Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis
  in human and murine mammary adenocarcinoma cells.
authors:
- Pidgeon GP
- Barr MP
- Harmey JH
- Foley DA
- Bouchier-Hayes DJ
journal: Br J Cancer
year: '2001'
full_text_available: false
full_text_extraction_method: xml_abstract_only
pmcid: PMC2364032
doi: 10.1054/bjoc.2001.1876
---

# Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells.
**Authors:** Pidgeon GP, Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ
**Journal:** Br J Cancer (2001)
**DOI:** [10.1054/bjoc.2001.1876](https://doi.org/10.1054/bjoc.2001.1876)
**PMC:** [PMC2364032](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364032/)

## Abstract

1. Br J Cancer. 2001 Jul 20;85(2):273-8. doi: 10.1054/bjoc.2001.1876.

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits 
apoptosis in human and murine mammary adenocarcinoma cells.

Pidgeon GP(1), Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ.

Author information:
(1)Department of Surgery, Royal College of Surgeons in Ireland, Beaumont 
Hospital, Beaumont, Dublin 9, Ireland.

Tumour progression is regulated by the balance of proliferation and apoptosis in 
the tumour cell population. To date, the role of vascular endothelial growth 
factor (VEGF) in tumour growth has been attributed to the induction of 
angiogenesis. VEGF has been shown to be a survival factor for endothelial cells, 
preventing apoptosis by inducing Bcl-2 expression. In both murine (4T1) and 
human (MDA-MB-231) metastatic mammary carcinoma cell lines, we found that VEGF 
upregulated Bcl-2 expression and anti-VEGF antibodies reduced Bcl-2 expression. 
These alterations in Bcl-2 expression were reflected by the levels of tumour 
cell apoptosis. VEGF resulted in reduced tumour cell apoptosis, whereas its 
inhibition with anti-VEGF neutralizing antibodies induced apoptosis directly in 
tumour cells. Therefore, in addition to its role in angiogenesis and vessel 
permeability, VEGF acts as a survival factor for tumour cells, inducing Bcl-2 
expression and inhibiting tumour cell apoptosis.

DOI: 10.1054/bjoc.2001.1876
PMCID: PMC2364032
PMID: 11461089 [Indexed for MEDLINE]

## Full Text

Tumour progression is regulated by the balance of proliferation and apoptosis in the tumour cell population. To date, the role of vascular endothelial growth factor (VEGF) in tumour growth has been attributed to the induction of angiogenesis. VEGF has been shown to be a survival factor for endothelial cells, preventing apoptosis by inducing Bcl-2 expression. In both murine (4T1) and human (MDA-MB-231) metastatic mammary carcinoma cell lines, we found that VEGF upregulated Bcl-2 expression and anti-VEGF antibodies reduced Bcl-2 expression. These alterations in Bcl-2 expression were reflected by the levels of tumour cell apoptosis. VEGF resulted in reduced tumour cell apoptosis, whereas its inhibition with anti-VEGF neutralizing antibodies induced apoptosis directly in tumour cells. Therefore, in addition to its role in angiogenesis and vessel permeability, VEGF acts as a survival factor for tumour cells, inducing Bcl-2 expression and inhibiting tumour cell apoptosis. Â© 2001 Cancer Research Campaign http://www.bjcancer.com
